Eruptive Keratoacanthomas Associated With Leflunomide

JAMA Dermatol. 2016 Jan;152(1):105-6. doi: 10.1001/jamadermatol.2015.2506.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antirheumatic Agents / administration & dosage
  • Antirheumatic Agents / adverse effects
  • Drug Eruptions / etiology*
  • Drug Eruptions / pathology
  • Female
  • Humans
  • Isoxazoles / administration & dosage
  • Isoxazoles / adverse effects*
  • Keratoacanthoma / chemically induced*
  • Keratoacanthoma / pathology
  • Leflunomide
  • Middle Aged
  • Skin Neoplasms / chemically induced*
  • Skin Neoplasms / pathology

Substances

  • Antirheumatic Agents
  • Isoxazoles
  • Leflunomide